|
Sep 4
|
NeuroPace Strengthens Management Team with Two Key Appointments
|
|
Aug 27
|
NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences
|
|
Jul 31
|
Waters (WAT) Q2 Earnings and Revenues Top Estimates
|
|
Jul 23
|
NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024
|
|
May 14
|
NeuroPace to Participate in Two Healthcare Conferences in May
|
|
May 13
|
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript
|
|
May 10
|
NeuroPace Inc (NPCE) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Ongoing Challenges
|
|
May 9
|
NeuroPace Inc (NPCE) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ...
|
|
May 8
|
NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
|
Apr 17
|
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
|
|
Apr 4
|
‘Time to Hit Buy,’ Says Wells Fargo About These 2 Stocks
|
|
Mar 27
|
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference
|
|
Mar 7
|
NeuroPace, Inc. (NASDAQ:NPCE) Q4 2023 Earnings Call Transcript
|
|
Mar 7
|
NeuroPace Full Year 2023 Earnings: EPS Beats Expectations
|
|
Mar 6
|
Q4 2023 Neuropace Inc Earnings Call
|
|
Mar 5
|
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
|
|
Mar 5
|
Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio
|
|
Dec 29
|
NeuroPace Inc Chief Medical Officer Martha Morrell Sells 13,402 Shares
|
|
Dec 21
|
NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study
|
|
Dec 19
|
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|